GO:1903412 response to bile acid: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1903412 (response to bile acid) describes any cellular or organismal process that changes in state or activity following a bile acid stimulus.
• Bile acids are not only detergents for fat digestion; they are potent signaling molecules that activate nuclear receptors such as FXR and membrane receptors such as TGR5.
• The gut microbiota chemically transforms primary bile acids into secondary bile acids, shaping the host response to bile acids.
• The bile acid-FXR/TGR5 axis regulates immunity, inflammation, glucose homeostasis, and energy metabolism.
• Dysregulated bile acid signaling is linked to colitis, metabolic disease, and carcinogenesis.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal dissection of genes mediating the response to bile acids.
Description
GO:1903412, response to bile acid, is a biological process Gene Ontology term that captures any change in the state or activity of a cell or organism as a result of a bile acid stimulus. Bile acids are steroid molecules synthesized from cholesterol in the liver and further metabolized by the gut microbiota; beyond their classical role in lipid absorption, they act as signaling hormones that modulate gene expression, secretion, movement, and metabolism. The term therefore encompasses a wide range of downstream events triggered when cells encounter bile acids such as cholic acid, chenodeoxycholic acid, deoxycholic acid, or lithocholic acid. Researchers study GO:1903412 because bile acid signaling is central to host-microbe interactions, immune regulation, and metabolic health. The response to bile acids is mediated by dedicated receptors, including the nuclear receptor FXR (NR1H4) and the G protein-coupled receptor TGR5 (GPBAR1), which transduce bile acid signals into transcriptional and second-messenger cascades. These pathways influence intestinal barrier function, postprandial GLP-1 secretion, and inflammatory tone, making the term highly relevant to gastroenterology, endocrinology, and oncology. Because the response to bile acids integrates microbial, metabolic, and immune inputs, it is a rich area for functional genomics. CRISPR screens and targeted editing allow researchers to identify which genes are required for bile acid sensing and which mediate its downstream effects. This article summarizes the definition, mechanisms, key genes, disease links, and experimental methods associated with GO:1903412.
response to bile acid At A Glance
| GO ID | GO:1903412 |
|---|---|
| GO term | response to bile acid |
| Ontology | biological_process |
| Synonym | none |
| Major function | Mediates cellular and organismal changes triggered by bile acid stimuli, including receptor activation, gene expression changes, secretion, and metabolic adaptation |
| Key receptors | FXR (NR1H4), TGR5 (GPBAR1), and other bile acid-responsive nuclear and membrane receptors |
| Microbiota role | Gut bacteria convert primary bile acids into secondary bile acids, modifying the stimulus and host response |
| Disease relevance | Inflammatory bowel disease, metabolic disorders, and carcinogenesis |
What Is GO:1903412?
In our own words, GO:1903412 (response to bile acid) refers to any process that results in a change in the state or activity of a cell or an organism in terms of movement, secretion, enzyme production, gene expression, or other activities, as a result of a bile acid stimulus. The term is a biological process and has no synonyms in the QuickGO entry. It covers the initial detection of bile acids by receptors and the downstream signaling, transcriptional, and physiological changes that follow.
Why Is response to bile acid Important in Cell Biology?
Understanding GO:1903412 is important because bile acids are pleiotropic signaling molecules that coordinate digestion, immunity, and metabolism, and their dysregulation contributes to major human diseases. The response to bile acids determines how the host tolerates microbial metabolites, controls inflammation, and maintains metabolic homeostasis, making it a central node in gut-liver axis research.
• Bile acids regulate their own synthesis via feedback inhibition of CYP7A1 through FXR signaling.
• The response to bile acids controls intestinal innate immunity and barrier function.
• TGR5 activation by bile acids stimulates GLP-1 secretion, linking bile acids to glucose homeostasis.
• Bile acid signaling through FXR/TGR5 modulates anti-inflammatory responses in colitis models.
• Secondary bile acids produced by the microbiota can promote or inhibit carcinogenesis depending on context.
• The bile acid-microbiota axis influences systemic immune function and metabolic health.
• Altered bile acid responses are observed in aging and age-related diseases.
• GO:1903412 provides a framework for interpreting multi-omics data in hepatology and gastroenterology.
What Happens During response to bile acid?
Bile acid synthesis and microbial modification
In simple terms: The body makes bile acids in the liver, and gut bacteria then change them into other forms.
Bile acids are synthesized from cholesterol in hepatocytes through classical and alternative pathways, generating primary bile acids such as cholic acid and chenodeoxycholic acid. After secretion into the intestine, the gut microbiota deconjugates, dehydroxylates, and epimerizes these molecules to produce secondary bile acids including deoxycholic acid and lithocholic acid. This microbial transformation alters the pool of bile acids available to stimulate host receptors, thereby shaping the response to bile acids.
Receptor-mediated detection of bile acids
In simple terms: Special sensor proteins on cells recognize bile acids and start a signal inside the cell.
The response to bile acids begins with their detection by dedicated receptors. The nuclear receptor FXR (NR1H4) binds bile acids and regulates transcription of target genes involved in bile acid homeostasis, lipid metabolism, and inflammation. The membrane receptor TGR5 (GPBAR1) activates G protein-dependent signaling, including cAMP production, in response to bile acids. Additional receptors such as the vitamin D receptor and pregnane X receptor also respond to bile acids, contributing to the overall cellular response.
Transcriptional and signaling cascades
In simple terms: Once sensors are activated, they switch genes on or off and trigger signaling chains.
Activated FXR translocates to the nucleus, binds DNA response elements, and modulates expression of genes such as SHP (NR0B2), FGF19, and OSTα/β, which control bile acid synthesis and transport. TGR5 activation triggers cAMP-PKA signaling and downstream effects on energy expenditure and inflammation. These cascades constitute the core molecular events of GO:1903412, converting a bile acid stimulus into changes in gene expression, secretion, and cell behavior.
Integration with immune and metabolic responses
In simple terms: Bile acid signals also talk to the immune system and metabolism.
Bile acid signaling intersects with immune pathways by modulating macrophage polarization, dendritic cell function, and T cell responses. In colitis models, the bile acid-FXR/TGR5 axis influences the response to anti-α4β7-integrin therapy, indicating that bile acid sensing shapes therapeutic outcomes. Metabolically, bile acid-TGR5 signaling in the ileum regulates postprandial GLP-1 secretion, linking the response to bile acids with glucose control. The gut microbiota-bile acid axis further integrates these immune and metabolic outputs.
Physiological outcomes and feedback
In simple terms: The final result is a coordinated change in digestion, metabolism, and inflammation.
The integrated response to bile acids includes feedback inhibition of bile acid synthesis, regulation of bile acid transport, and modulation of energy homeostasis. FXR activation in the intestine induces FGF19, which signals to the liver to suppress CYP7A1, completing a negative feedback loop. TGR5-mediated GLP-1 release improves glucose tolerance. These physiological outcomes demonstrate how GO:1903412 coordinates multiple organ systems to maintain homeostasis.
Key Genes Involved in GO:1903412 response to bile acid
The following genes and proteins are central to the detection, signaling, and physiological effects of the response to bile acids.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NR1H4 (FXR) | Nuclear receptor that binds bile acids and regulates transcription of genes controlling bile acid, lipid, and glucose metabolism | Central mediator of the response to bile acids; target for metabolic and cholestatic disease research |
| GPBAR1 (TGR5) | Membrane G protein-coupled receptor that activates cAMP signaling in response to bile acids | Links bile acid sensing to GLP-1 secretion, energy expenditure, and inflammation |
| CYP7A1 | Rate-limiting enzyme in the classical bile acid synthesis pathway | Feedback target of FXR-FGF19 signaling; key for studying bile acid homeostasis |
| FGF19 | Intestinal hormone induced by FXR that suppresses hepatic bile acid synthesis | Biomarker and therapeutic candidate in bile acid-related metabolic disease |
| NR0B2 (SHP) | Orphan nuclear receptor induced by FXR that inhibits CYP7A1 transcription | Negative feedback regulator of bile acid synthesis |
| ABCB11 (BSEP) | Bile salt export pump that transports bile acids from hepatocytes into bile | Mutations cause cholestasis; important for bile acid transport studies |
| SLC10A2 (ASBT) | Ileal apical sodium-dependent bile acid transporter | Mediates intestinal bile acid uptake; target for bile acid malabsorption research |
| VDR | Nuclear receptor activated by secondary bile acids such as lithocholic acid | Links bile acid sensing to calcium homeostasis and detoxification |
| PXR (NR1I2) | Xenobiotic receptor activated by bile acids, inducing detoxification enzymes | Protects against bile acid toxicity; relevant to drug metabolism |
| IL-10 | Anti-inflammatory cytokine modulated by bile acid signaling | Bile acid-immune crosstalk in colitis and tolerance |
| NLRP3 | Inflammasome component influenced by bile acid signaling | Bile acid regulation of innate immunity |
| GLP-1 (GCG) | Incretin hormone whose secretion is stimulated by bile acid-TGR5 signaling | Connects bile acid response to glucose homeostasis |
| MUC2 | Mucin protein supporting intestinal barrier, influenced by bile acids | Barrier function in bile acid-related colitis models |
| CYP27A1 | Sterol 27-hydroxylase in the alternative bile acid synthesis pathway | Alternative pathway for bile acid production |
| AKR1D1 | Enzyme in bile acid synthesis | Defects cause bile acid synthesis disorders |
| SLC51A/B (OSTα/β) | Heteromeric transporter for bile acid efflux | Regulated by FXR; important for bile acid transport |
How Is response to bile acid Regulated?
The response to bile acid is tightly regulated by feedback loops. FXR activation in the intestine induces FGF19, which travels to the liver and suppresses CYP7A1, reducing bile acid synthesis. Hepatic FXR induces SHP (NR0B2), which also inhibits CYP7A1. TGR5 signaling is regulated by G protein-coupled receptor kinases and arrestins, which desensitize the receptor after activation. The gut microbiota modulates the bile acid pool composition, thereby influencing the intensity and specificity of receptor activation. Additionally, circadian rhythms and nutritional status affect bile acid synthesis and signaling.
response to bile acid and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NR1H4 (FXR) | Cholestasis, metabolic syndrome, colitis | FXR knockout mice; intestinal epithelial cell-specific KO |
| GPBAR1 (TGR5) | Type 2 diabetes, obesity, inflammation | TGR5 knockout mice; GLP-1 secretion assays |
| CYP7A1 | Bile acid synthesis disorders, gallstones | Liver-specific CYP7A1 knockout mice |
| FGF19 | Metabolic disease, bile acid diarrhea | FGF19 transgenic or knockout mice |
| ABCB11 (BSEP) | Progressive familial intrahepatic cholestasis | BSEP knockout mice; patient-derived organoids |
Inflammatory bowel disease and colitis
Alterations in bile acid metabolism and signaling are associated with inflammatory bowel disease. In humanized mice with colitis, the gut microbiota-related bile acid metabolism-FXR/TGR5 axis impacts the response to anti-α4β7-integrin therapy, suggesting that bile acid signaling influences treatment efficacy. Bile acids also shape host immunity, with effects on macrophage and T cell function that can exacerbate or ameliorate intestinal inflammation.
Metabolic disorders and glucose homeostasis
The response to bile acids is linked to postprandial GLP-1 secretion via ileal bile acid-TGR5 signaling, which affects glucose homeostasis. Dysregulation of FXR and TGR5 signaling is implicated in obesity, insulin resistance, and non-alcoholic fatty liver disease. The gut microbiota-bile acid axis is considered a crucial regulator of metabolic health.
Carcinogenesis
Bile acids can promote carcinogenesis in the esophagus, stomach, colon, and liver, particularly when chronic exposure occurs in the context of reflux or inflammation. Secondary bile acids such as deoxycholic acid have been shown to induce DNA damage and activate survival pathways. The role of bile acids in carcinogenesis is context-dependent, with some bile acids exhibiting protective effects through FXR and TGR5.
From response to bile acid-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is FXR required for bile acid-mediated feedback inhibition of CYP7A1? | FXR knockout (KO) mice or hepatocyte-specific FXR KO |
| Does a specific point mutation in TGR5 alter cAMP signaling? | Point-mutation knock-in mice or cells expressing mutant TGR5 |
| Can a tagged FXR be used to map genomic binding sites? | Tagged knock-in of FXR (e.g., FLAG or HA) followed by ChIP-seq |
| Does overexpression of FGF19 protect against cholestasis? | Transgenic overexpression of FGF19 in mice |
| Which genes are essential for bile acid-induced GLP-1 secretion? | CRISPR knockout library screening in enteroendocrine cell lines |
| How does the microbiota shape the response to bile acids? | Germ-free or antibiotic-treated mice with fecal microbiota transplantation |
How to Study the response to bile acid Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify FXR/TGR5 target genes after bile acid treatment |
| ChIP-seq | Genomic binding sites of FXR or other transcription factors | Map FXR cistrome in liver or intestine |
| Mass spectrometry | Bile acid species and concentrations | Profile bile acid pool in feces and serum |
| CRISPR knockout screen | Genes required for bile acid response | Discover regulators of GLP-1 secretion or FXR activity |
| cAMP assay | TGR5 activation | Measure bile acid-induced cAMP in cells |
| Organoid culture | Epithelial response to bile acids | Model intestinal barrier and inflammation |
| 16S rRNA sequencing | Microbiota composition | Correlate microbial taxa with bile acid profiles |
| Western blot | Protein expression and signaling | Detect FXR, SHP, or FGF19 induction |
Transcriptomic profiling
RNA-seq is widely used to measure gene expression changes following bile acid stimulation, revealing FXR and TGR5 target genes. This method can identify global transcriptional responses in hepatocytes, intestinal epithelial cells, or immune cells treated with bile acids.
Metabolomics and bile acid profiling
Mass spectrometry-based bile acid profiling quantifies primary and secondary bile acids in serum, bile, feces, and tissues. This approach is essential for linking microbiota composition to the bile acid pool and the host response.
CRISPR screening
Genome-wide CRISPR knockout or activation screens can identify genes that regulate the response to bile acids, such as those required for TGR5-mediated GLP-1 secretion or FXR-dependent transcription. These screens provide unbiased discovery of novel pathway components.
Imaging and reporter assays
Fluorescent bile acid analogs and reporter cell lines (e.g., cAMP reporters for TGR5) enable real-time monitoring of bile acid uptake and signaling. Imaging of bile acid transport in polarized cells can reveal spatial dynamics of the response.
How CRISPR Can Be Used to Study GO:1903412 response to bile acid
Knockout
CRISPR knockout of genes such as NR1H4 (FXR) or GPBAR1 (TGR5) in cell lines or mice allows researchers to test their requirement in the response to bile acids. For example, FXR knockout hepatocytes fail to suppress CYP7A1 in response to bile acids, confirming the feedback loop.
Point Mutation
Point mutations can be introduced into bile acid receptor genes to dissect specific residues required for ligand binding or signaling. For instance, mutating key residues in the TGR5 ligand-binding pocket can abolish cAMP activation while preserving surface expression.
Knock-in
Knock-in of epitope tags (e.g., FLAG, HA) into endogenous FXR or TGR5 loci enables chromatin immunoprecipitation and proteomic studies without overexpression artifacts. Knock-in of humanized receptors can also create models for testing human-specific bile acid responses.
Overexpression
Overexpression of FGF19 or constitutively active FXR in mice can amplify bile acid signaling and reveal downstream physiological effects, such as protection against cholestasis or improved glucose tolerance.
How EDITGENE Supports response to bile acid Research
Researchers studying response to bile acid-related genes often need to determine whether a candidate gene is causally involved in bile acid sensing, signaling, or downstream physiology. EDITGENE provides CRISPR-based cell models and screening services to enable such causal studies.
Contact EDITGENE today to design your custom CRISPR model for response to bile acid research.
Frequently Asked Questions About response to bile acid
What is GO:1903412?
GO:1903412 is the Gene Ontology term for response to bile acid, defined as any process that results in a change in state or activity of a cell or organism as a result of a bile acid stimulus.
What genes are involved in response to bile acid?
Key genes include NR1H4 (FXR), GPBAR1 (TGR5), CYP7A1, FGF19, NR0B2 (SHP), ABCB11 (BSEP), and SLC10A2 (ASBT).
How do bile acids signal in cells?
Bile acids activate nuclear receptors like FXR and membrane receptors like TGR5, triggering transcriptional and second-messenger cascades.
What is the role of the gut microbiota in response to bile acid?
Gut bacteria convert primary bile acids into secondary bile acids, altering the pool of molecules that stimulate host receptors.
Which diseases are linked to bile acid signaling?
Inflammatory bowel disease, metabolic disorders, cholestasis, and cancers of the gastrointestinal tract are linked to bile acid signaling.
How can CRISPR be used to study response to bile acid?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of genes involved in bile acid sensing and downstream effects.
What is the FXR-FGF19 feedback loop?
Intestinal FXR activation by bile acids induces FGF19, which suppresses hepatic CYP7A1 and reduces bile acid synthesis.
Does TGR5 regulate GLP-1 secretion?
Yes, bile acid-TGR5 signaling in the ileum regulates postprandial GLP-1 secretion, linking bile acids to glucose homeostasis.
What methods are used to study response to bile acid?
Common methods include RNA-seq, ChIP-seq, mass spectrometry, CRISPR screens, cAMP assays, and organoid culture.
Why is response to bile acid important for immunity?
Bile acids shape host immunity by modulating macrophage, dendritic cell, and T cell functions, influencing inflammation and tolerance.
Conclusion
GO:1903412 (response to bile acid) is a fundamental biological process that integrates bile acid chemistry, microbial metabolism, and host signaling to control metabolism, immunity, and disease. The FXR and TGR5 receptors are central mediators, and their downstream effects on gene expression, secretion, and inflammation are actively studied. Dysregulation of this process contributes to colitis, metabolic disorders, and carcinogenesis. CRISPR-based models and functional genomics approaches are powerful tools for dissecting the genes and pathways that mediate the response to bile acids. EDITGENE provides comprehensive services to support such research, from knockout and knock-in cell models to CRISPR library screening and bioinformatics analysis.
References
- 1. Di Ciaula A et al.. 2017. Bile Acid Physiology.. Ann Hepatol 16(Suppl. 1: s3-105.):s4-s14 PMID: 29080336
- 2. Han B et al.. 2023. Gut microbiota-related bile acid metabolism-FXR/TGR5 axis impacts the response to anti-α4β7-integrin therapy in humanized mice with colitis.. Gut Microbes 15(1):2232143 PMID: 37431863
- 3. Wang Q et al.. 2023. Gut microbiota regulates postprandial GLP-1 response via ileal bile acid-TGR5 signaling.. Gut Microbes 15(2):2274124 PMID: 37942583
- 4. Ramírez-Pérez O et al.. 2017. The Role of the Gut Microbiota in Bile Acid Metabolism.. Ann Hepatol 16(Suppl. 1: s3-105.):s15-s20 PMID: 29080339
- 5. Lee MH et al.. 2024. How bile acids and the microbiota interact to shape host immunity.. Nat Rev Immunol 24(11):798-809 PMID: 39009868
- 6. Perino A et al.. 2021. Molecular Physiology of Bile Acid Signaling in Health, Disease, and Aging.. Physiol Rev 101(2):683-731 PMID: 32790577
- 7. Režen T et al.. 2022. The role of bile acids in carcinogenesis.. Cell Mol Life Sci 79(5):243 PMID: 35429253
- 8. Tyagi A et al.. 2025. The gut microbiota-bile acid axis: a crucial regulator of immune function and metabolic health.. World J Microbiol Biotechnol 41(7):215 PMID: 40555888
